Sangamo Therapeutics Inc (NASDAQ: SGMO) is -40.00% lower on its value in year-to-date trading and has touched a low of $0.30 and a high of $3.18 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The SGMO stock was last observed hovering at around $0.72 in the last trading session, with the day’s loss setting it -0.11%.
Currently trading at $0.61, the stock is -15.89% and -24.57% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 7.25 million and changing -15.00% at the moment leaves the stock -49.04% off its SMA200. SGMO registered 17.24% gain for a year compared to 6-month loss of -64.00%.
The stock witnessed a -6.78% gain in the last 1 month and extending the period to 3 months gives it a -50.65%, and is -15.15% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 11.19% over the week and 11.97% over the month.
Sangamo Therapeutics Inc (SGMO) has around 183 employees, a market worth around $137.52M and $57.80M in sales. Profit margin for the company is -171.67%. Distance from 52-week low is 101.32% and -80.75% from its 52-week high. The company has generated returns on investments over the last 12 months (-202.41%).
with sales reaching $7.42M over the same period.The EPS is expected to grow by 44.04% this year, but quarterly earnings will post 7.66% year-over-year. Quarterly sales are estimated to grow 1,441.93% in year-over-year returns.
Sangamo Therapeutics Inc (SGMO) Top Institutional Holders
The shares outstanding are 224.71M, and float is at 214.84M with Short Float at 13.83%.
The top institutional shareholder in the company is WASATCH ADVISORS LP with over 20.09 million shares valued at $7.2 million. The investor’s holdings represent 9.8509% of the SGMO Shares outstanding. As of 2024-06-30, the second largest holder is ARMISTICE CAPITAL, LLC with 14.06 million shares valued at $5.04 million to account for 6.894 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 11.9 million shares representing 5.8341% and valued at over $4.26 million, while BLACKROCK INC. holds 2.306 of the shares totaling 4.7 million with a market value of $1.69 million.
Sangamo Therapeutics Inc (SGMO) Insider Activity
#####
